EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Perspectives in the Management of Triple-Negative Breast Cancer

Rupert Bartsch, Zsuzsanna Bago-Horvath, Daniel Egle, Simon P Gampenrieder, Birgit Grünberger, Sonja Heibl, Maximilian Marhold, Caroline Preuss, Gabriel Rinnerthaler, Kathrin Strasser-Weippl, Christoph Suppan, Christian F Singer und 1 weitere

Breast Care · 15.08.2025 · 21 (2) · 152-165

DOI: 10.1159/000547988 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Breast Care, online erschienen am 15.08.2025. Verfasst von Rupert Bartsch und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 1, Division of Oncology, Medical University of Vienna, Vienna, Austria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: The biological heterogeneity of triple-negative breast cancer (TNBC) and the availability of a growing number of therapeutic options necessitate continuous redefinition of the ideal treatment algorithm for patients with TNBC. Austrian experts convened for an advisory board meeting in November 2024 to discuss standards of care in the early and metastatic settings with a focus on the healthcare situation in Austria. Summary: This paper discusses biological principles, (neo)adjuvant treatment standards and strategies of escalation and de-escalation, as well as standards of care, new treatment options, and the management of central nervous system (CNS) disease in the setting of metastatic TNBC. Key Messages: TNBC remains a high-risk subtype of breast cancer. Neoadjuvant chemotherapy is preferred in early-stage disease starting from cT1c, cN0, with the addition of pembrolizumab recommended from clinical stage II. Post-neoadjuvant treatment is guided by the pathological response and BRCA mutation status, while ongoing trials are evaluating the role of antibody-drug conjugates in this setting. In metastatic TNBC, assessment of PD-L1 expression and BRCA mutation status is essential for optimal sequencing of available treatment options. CNS involvement remains a major clinical challenge.

Schlagwörter

Stichwörter der Autor:innen

DiagnosisTreatmentTriple-negative breast cancer recommendations

Autor:innen und Institutionen

  • Department of Medicine 1, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria.
  • Klinisches Institut für Pathologie, Comprehensive Cancer Center, Medizinische Universität Wien, Vienna, Austria.
  • BrustGesundheitZentrum, Klinische Abteilung für Gynäkologie und Geburtshilfe, Medizinische Universität Innsbruck, Innsbruck, Austria.
  • Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular C…
  • Klinische Abteilung für Innere Medizin III, Hämatologie und internistische Onkologie, Universitäts-Klinikum Wiener Neustadt, Wiener Neustadt, Austria.

Zitieren

APA

Bartsch, R., Bago-Horvath, Z., Egle, D., Gampenrieder, S. P., Grünberger, B., Heibl, S., Marhold, M., Preuss, C., Rinnerthaler, G., Strasser-Weippl, K., Suppan, C., Singer, C. F., & Gnant, M. (2025). New Perspectives in the Management of Triple-Negative Breast Cancer. Breast Care, 21(2), 152-165. https://doi.org/10.1159/000547988

Vancouver

Bartsch R, Bago-Horvath Z, Egle D, Gampenrieder SP, Grünberger B, Heibl S, et al. New Perspectives in the Management of Triple-Negative Breast Cancer. Breast Care. 2025;21(2):152-165. doi:10.1159/000547988

BibTeX
@article{Bartsch2025,
  author = {Bartsch, Rupert and Bago-Horvath, Zsuzsanna and Egle, Daniel and Gampenrieder, Simon P and Grünberger, Birgit and Heibl, Sonja and Marhold, Maximilian and Preuss, Caroline and Rinnerthaler, Gabriel and Strasser-Weippl, Kathrin and Suppan, Christoph and Singer, Christian F and Gnant, Michael},
  title = {New Perspectives in the Management of Triple-Negative Breast Cancer},
  journal = {Breast Care},
  year = {2025},
  volume = {21},
  number = {2},
  pages = {152--165},
  doi = {10.1159/000547988}
}
Kostenlos starten →